• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.

作者信息

Nishikimi Akihiko, Nakagawa Takeshi, Fujiwara Mitsuhiro, Watanabe Ken, Watanabe Atsushi, Komatsu Ayane, Yasuoka Mikako, Watanabe Ryota, Naya Masahiro, Oshima Hironori, Kitagawa Yuichi, Tokuda Haruhiko, Kondo Izumi, Niida Shumpei, Sakurai Takashi, Kojima Masayo, Arai Hidenori

机构信息

Biosafety Administration Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.

Department of Social Science, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.

出版信息

J Infect. 2023 Feb;86(2):e33-e35. doi: 10.1016/j.jinf.2022.10.026. Epub 2022 Oct 21.

DOI:10.1016/j.jinf.2022.10.026
PMID:36273645
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9584759/
Abstract
摘要

相似文献

1
Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.日本研究机构工作人员对第三剂新冠病毒疫苗BNT162b2的体液和细胞免疫反应
J Infect. 2023 Feb;86(2):e33-e35. doi: 10.1016/j.jinf.2022.10.026. Epub 2022 Oct 21.
2
Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.日本某研究所工作人员对新冠疫苗BNT162b2的免疫反应：6个月随访调查
J Infect. 2022 Aug;85(2):174-211. doi: 10.1016/j.jinf.2022.05.016. Epub 2022 May 20.
3
Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan.抑郁症状可预测日本医护人员接种第二剂 SARS-CoV-2 BNT162b2 疫苗后的抗体滴度。
Brain Behav Immun. 2023 Jan;107:414-418. doi: 10.1016/j.bbi.2022.09.004. Epub 2022 Sep 15.
4
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational Study.针对第三剂 BNT162b2 COVID-19 疫苗的细胞和体液免疫反应 - 一项前瞻性观察研究。
Front Immunol. 2022 Jul 1;13:896151. doi: 10.3389/fimmu.2022.896151. eCollection 2022.
5
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.第三剂 BNT162b2 COVID-19 mRNA 疫苗对医护人员抗 SARS-CoV-2 抗体水平的影响。
Vaccine. 2023 Jan 9;41(2):365-371. doi: 10.1016/j.vaccine.2022.11.049. Epub 2022 Nov 24.
6
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.多发性硬化症患者接受芬戈莫德治疗后，对第三剂 COVID-19 疫苗的免疫反应与淋巴细胞计数有关。
J Neurol. 2022 May;269(5):2286-2292. doi: 10.1007/s00415-022-11030-0. Epub 2022 Mar 2.
7
Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare Workers.日本医护人员接种第三剂BNT162b2疫苗后对严重急性呼吸综合征冠状病毒2的体液免疫和细胞免疫增强作用
J Infect Dis. 2023 Jan 11;227(2):221-225. doi: 10.1093/infdis/jiac344.
8
Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan.日本5至11岁儿童对BNT162b2新冠疫苗的不良反应及态度
J Epidemiol. 2023 Feb 5;33(2):110-111. doi: 10.2188/jea.JE20220265. Epub 2022 Nov 30.
9
Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers.日本医护人员接种 BNT162b2 新冠疫苗第三针后的免疫应答。
J Infect Chemother. 2022 Nov;28(11):1478-1482. doi: 10.1016/j.jiac.2022.07.006. Epub 2022 Jul 31.
10
Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.青少年肝移植患者对辉瑞-生物科技 BNT162b2 SARS-CoV-2 疫苗的体液和细胞免疫反应：单中心经验。
Front Immunol. 2022 Nov 23;13:1049188. doi: 10.3389/fimmu.2022.1049188. eCollection 2022.

引用本文的文献

1
Enriched CXCR3 CXCR5 CD8 T cells in SARS-CoV-2 infected and vaccinated individuals effectively respond to the antigen in recall.在感染和接种过新冠病毒的个体中，富集的CXCR3、CXCR5 CD8 T细胞在再次接触抗原时能有效应答。
J Infect. 2023 May;86(5):497-499. doi: 10.1016/j.jinf.2023.02.022. Epub 2023 Feb 23.